Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:om425

Total Results:

44


Lessons learned on access, equity, and collaboration between public hospital Infectious Diseases leadership and the Health Department during the 2025 Legionnaires'disease outbreak response in New York City [Editorial]

Ratcliffe, Judith; Lamb, Kelsey; Martin, Madhuri; Chan, Justin; McGibbon, Emily; McPherson, Tristan; Episcopia, Briana; Mukherjee, Vikramjit; Wallach, Andrew; Mannheimer, Sharon; Mgbako, Ofole
This commentary presents lessons learned and unique aspects of the public health response of infectious disease physicians, infection prevention and control specialists, and the New York City Health Department to the 2025 Legionella outbreak in Harlem.
PMCID:13760290
PMID: 43032319
ISSN: 2732-494x
CID: 6075949

Lessons learned on access, equity, and collaboration between public hospital Infectious Diseases leadership and the Health Department during the 2025 Legionnaires’disease outbreak response in New York City

Ratcliffe, Judith; Lamb, Kelsey; Martin, Madhuri; Chan, Justin; McGibbon, Emily; McPherson, Tristan; Episcopia, Briana; Mukherjee, Vikramjit; Wallach, Andrew; Mannheimer, Sharon; Mgbako, Ofole
This commentary presents lessons learned and unique aspects of the public health response of infectious disease physicians, infection prevention and control specialists, and the New York City Health Department to the 2025 Legionella outbreak in Harlem.
ORIGINAL:7248963
ISSN: 2732-494x
CID: 6074498

Barriers and Facilitators to Equitable Implementation of Long-Acting Injectable PrEP for Racial, Gender and Sexual Minority Populations in NYC: The EquiPrEP Study

Mgbako, Ofole; Kaplan-Lewis, Emma; Casey, Eunice; Mishra, Maya; Goldfarb, Ellie; Moore, Brandi; Kapadia, Farzana; Khan, Maria; Lim, Sahnah; Felder, Jason; Ratcliffe, Judith; Tillery, Eishelle H; Duke, Sharen; Morales Correa, Gustavo A; Goldberg-Hall, Emily; Pitts, Robert
Long-acting injectable cabotegravir (LAI-CAB) is a novel HIV pre-exposure prophylaxis (PrEP) modality found to significantly lower HIV risk in key populations. EquiPrEP was an observational implementation science study to examine multilevel barriers and facilitators to LAI-CAB implementation among Black and/or Latine MSM, Black and/or Latine cisgender women, and transgender and nonbinary persons. This study took place at the Pride Health Center (PHC) at NYC Health+Hospitals (H+H)/Bellevue in New York City (February 2023-February 2025). Sociodemographic and health related social needs screening data were collected from EquiPrEP participants via a survey. We conducted in-depth interviews with study participants (N=26) and implementers (N=25) guided by The Consolidated Framework for Implementation Research 2.0. Descriptive statistics were used to assess sociodemographics for all EquiPrEP participants versus those recruited for in-depth interviews. Qualitative data was analyzed using thematic content analysis. Comparing all EquiPrEP participants (N=129) with the subgroup (N=26), the subgroup was older, with more Black cisgender MSM, and transgender women, a higher percentage ever on oral PrEP, and referred from an external clinic. Facilitators included open communication among staff, a patient-centered culture of care delivery and the EquiPrEP Navigator. Barriers included distance to clinical services, financial issues and insurance access. EquiPrEP is one of the first LAI-CAB implementation studies for HIV prevention to center equitable access for communities with the highest burden of HIV and elucidate implementation determinants to LAI-CAB. Findings may inform future implementation strategies seeking to incorporate equity as part of LAI-PrEP care.
PMID: 42786370
ISSN: 1573-3254
CID: 6073572

Honoring the Legacy of the HIV Epidemic

Mgbako, Ofole
PMID: 42734223
ISSN: 1533-4406
CID: 6072868

Clinical Outcomes of Mpox Disease in Patients Treated with Tecovirimat

Leocadio, Ciarra; Garcia, Elizabeth; Lash, Maura; Berardi, Jonathan; Chan, Justin; Chasan, Rachel; Esquivel, Blanca; Foote, Mary; Glesby, Marshall J; Guerra, Amiyah; Harris, Alexander B; Knutsen, Dorothy; Mannheimer, Sharon; Mazo, Dana; McLean, Jacob; McPherson, Tristan; Meyerowitz, Eric; Mgbako, Ofole; Patel, Gopi; Pagán Pirallo, Patricia M; Radix, Asa E; Riska, Paul; Sayegh, Mark; Seifu, Leah; Shaw, Raphael; Zingman, Barry; Zomorodi, Rustin; Zucker, Jason; Wong, Marcia
BACKGROUND:There is emerging literature describing clinical characteristics and outcomes in patients with mpox treated with tecovirimat. METHODS:We analyzed retrospective deidentified data from healthcare systems in New York City with the highest number of tecovirimat prescriptions. Individuals with probable or confirmed mpox initiating tecovirimat from May-December 2022 were included. A chart abstraction instrument was used to extract demographic and clinical data from medical records. We examined factors associated with delay in treatment and hospitalization. RESULTS:A total of 708 individuals prescribed tecovirimat for mpox were included in the analysis; median age was 36 years (IQR 31-43); 566 (80%) were cisgender men who have sex with men; and 399 (56%) were living with HIV. Side effects (100, 14%) and severe adverse events (7, 1%) were rare. The most common long-term sequela was scarring (69, 10%). One hundred and one (14%) were hospitalized. Median time from symptom onset to treatment initiation was 8 days (IQR 6-11). Non-Hispanic Black patients had higher risk of initiating tecovirimat ≥8 days after symptom onset (relative risk [RR]=1.3, 95%CI: 1.2-1.7) and being hospitalized (adjusted relative risk [aRR]=2.2, 95%CI: 1.4-3.5) compared with Hispanic patients, after adjusting for HIV and insurance status. CONCLUSIONS:We described common reasons for tecovirimat initiation and hospitalization. There were racial inequities in hospitalization and treatment delays. More research and focused efforts to mitigate these inequities are needed. These findings may better inform decisions for treatment initiation and hospitalization for mpox.
PMID: 40974008
ISSN: 1537-6591
CID: 5935702

A Just Appraisal: Co-creating a New Health Equity Framework with Learners through Journal Club to Evaluate the Literature

Mgbako, Ofole; Gonzalez, Cristina M; Olagun-Samuel, Christine; Torres, Christian; Richardson, Safiya; Williams, Renee; Greene, Richard E; Ortiz, Robin
BACKGROUND:Health equity is receiving increased attention in medical education. However, guidance is often lacking on how to integrate health equity into routine medical education. Journal club presents an opportunity to deepen medical educators' and learners' understanding of health equity principles and use it as a lens through which to critically appraise the literature. AIM/OBJECTIVE:We present a health equity framework, iteratively co-created by faculty and learners, that can be applied in a journal club setting. SETTING/METHODS:Academic medical center in New York City, USA. PARTICIPANTS/METHODS:Faculty, residency program directors, medical students, and residents. PROGRAM DESCRIPTION/METHODS:Authors developed the health equity journal club framework during a medical student selective course. Learner and faculty applied the framework to journal club articles; their feedback informed revisions. Framework domains included authorship, ethics, methodology, language, peer review, and references. PROGRAM EVALUATION/RESULTS:Learner evaluations were overall positive, and 86% (n = 13) of responding residency program directors (n = 15) across 15 departments who were surveyed plan to use the framework moving forward. DISCUSSION/CONCLUSIONS:A health equity journal club framework applied to critical appraisal of the literature may facilitate health equity as a routine part of medical education. Co-creating the framework proved vital to inclusion of learner voices.
PMID: 40760378
ISSN: 1525-1497
CID: 5904892

Health insurance status and severe mpox disease outcomes among sexual minority men in NYC: a retrospective cohort study

Mgbako, Ofole; Castellano, Cecilia; Jano, Kathryn; Piccolo, Anthony Lo; DiLorenzo, Madeline A; Knutsen, Dorothy; Shah, Yusra; Pressley, Joyce C; Duncan, Dustin T; Felder, Jason; Mazo, Dana
BACKGROUND:The 2022-2023 global mpox outbreak predominantly affected sexual minority men, with notable racial/ethnic disparities in the USA. While the current literature has established the clinical predictors of severe mpox disease, little is known about the role of insurance status on clinical outcomes. We sought to characterize patients diagnosed with mpox in New York City (NYC) and examine associations between insurance status and mpox severity score (mpox-SS). METHODS:), prior vaccination with JYNNEOS or a smallpox vaccine, presence of a sexually transmitted infection (STI), and CDC Social Vulnerability Index. RESULTS:The mean age (SD) was 38.3 (10.2) years with 53 (37.1%) identifying as non-Hispanic White, 44 (30.8%) as Hispanic/Latino, and 30 (20.9%) as non-Hispanic Black. Over 90% were male sex at birth or identified as cisgender men and approximately 80% were sexual minority men. Ninety-six (67.1%) had private insurance, 6 (4.2%) Medicare, 35 (24.5%) Medicaid, and 4 were (2.8%) uninsured. Sixty-three (44.1%) had a confirmed HIV diagnosis, 25 (17.4%) patients had prior JYNNEOS vaccination, and 31 (21.7%) had a high-risk condition. Thirty-eight (26.6%) patients received tecovirimat; 21 (14.7%) patients were hospitalized, with 4 (2.8%) of those admitted to the ICU. The mean (SD) mpox-SS was 6.85 (3.36). In univariate analysis, lack of insurance or Medicaid status was associated significantly with more severe mpox-SS. Insurance status remained significant (p = 0.03) in multivariable models. CONCLUSIONS:Being uninsured or on Medicaid was significantly associated with a higher mpox-SS in this diverse cohort of predominantly cisgender sexual minority men in NYC. High-risk status and lack of prior vaccination were associated with higher mpox-SS. Further studies are needed to assess the relationship between insurance, delays in access to care, or other socioeconomic inequities with severe mpox to understand the inequities beyond insurance access to prevent disparities in future outbreaks.
PMCID:12239370
PMID: 40629412
ISSN: 1741-7015
CID: 5890732

Severe Mpox Among People With Advanced Human Immunodeficiency Virus Receiving Prolonged Tecovirimat in New York City

Garcia, Elizabeth A; Foote, Mary M K; McPherson, Tristan D; Lash, Maura K; Bosompem, Amma N; Bouscaren, Alyssa; Chan, Justin; DiLorenzo, Madeline A; Feihel, Dennis; Fowler, Randal C; Gandhi, Vani; Jenny-Avital, Elizabeth R; Kopping, Erik J; Mazo, Dana; McLean, Jacob; Mgbako, Ofole; Sayegh, Mark N; Shaw, Raphael N; Su, Michelle; Meissner, Jeanne Sullivan; Wang, Jade C; Wen, Wendy; Winters, John C; Zeana, Cosmina B; Zucker, Jason; Wong, Marcia
Severe mpox has been observed in people with advanced human immunodeficiency virus (HIV). We describe clinical outcomes of 13 patients with advanced HIV (CD4 <200 cells/μL), severe mpox, and multiorgan involvement. Despite extended tecovirimat courses and additional agents, including vaccinia immune globulin, cidofovir, and brincidofovir, this group experienced prolonged hospitalizations and high mortality.
PMCID:11168585
PMID: 38868307
ISSN: 2328-8957
CID: 5668382

The Role of the Multidisciplinary HIV Care Center in Mitigating Social Isolation Among Patients with HIV During the Early COVID-19 Pandemic

Mgbako, Ofole; Loughran, Claire; Vaughn, Michael P; Felder, Jason; Augustin, Ashley; Gordon, Peter; Remien, Robert H; Olender, Susan
As the COVID-19 pandemic began in 2020, significant public health mitigation efforts were vital to combat an unprecedented health crisis. These efforts, which involved social distancing and self-quarantine, likely worsened a public health crisis of social isolation and loneliness in the U.S., particularly among people with HIV (PWH). Multidisciplinary HIV care centers, which served as the main source of clinical care for PWH and in some cases the only point of social contact, faced evolving dynamics of in-person visits during the COVID-19 pandemic, as well as a shift to telehealth services. Using in-depth interviews, we explored the role that multidisciplinary HIV care centers and providers played in the experience of social isolation among PWH in New York City. We recruited participants (n = 30) from a multidisciplinary HIV care center in NYC between October 2020 and June 2021. We conducted semi-structured interviews to understand the specific domains of social isolation that were mitigated. In this cohort, the major theme that drove both in-person and telehealth care continuity was the strength of the patient-provider relationship. We found that participants saw members of the HIV care center as part of their social network, and providers served both as a source of emotional support and provided important social resources and benefits. Thus, in times of heightened social isolation, HIV care centers can play a critical role in providing social support in addition to clinical care.
PMID: 38856843
ISSN: 1573-3254
CID: 5668822

Immediate ART and clinical outcomes in New York City among patients newly diagnosed with HIV

Mgbako, Ofole; Mathu, Rachel; Gonzalez Davila, Mila; Mehta, Monica; Cabrera, Joselyn; Carnevale, Caroline; Zucker, Jason; Gordon, Peter; Olender, Susan
Immediate antiretroviral therapy (iART) has been shown to decrease time to viral suppression. Our center underwent significant practice transformation to support iART, including a same-day Open Access (OA) model and enhanced care coordination. We examined whether same-day ART at linkage was associated with favorable proximate and long-term HIV care outcomes. From 2018 to 2019, patients newly diagnosed with HIV, linked to care at our institution, and iART eligible were included. We evaluated the association between iART and time to viral suppression, and between iART and initial/sustained viral suppression and retention in care. We also evaluated the association between use of OA and frequency of care coordination with the same outcomes. Of the 107 patients included, 72 initiated same-day ART at linkage and 35 did not. There was no statistically significant differences in whether patients were ever suppressed, had sustained viral suppression, or were retained in care between those who received same-day ART and those who did not. More care coordination was associated with retention in care (RR 1.21 [1.01-1.5]; p = 0.05). Organizing vital services and ensuring implementation strategies that facilitate iART, while tailoring the approach to the patient's comfort level, is likely optimal for longitudinal HIV care engagement.
PMCID:9880246
PMID: 35895602
ISSN: 1360-0451
CID: 5740422